Cohesys
PrivateLast Round
Grant
Oct 13, 2025
Total Funding Raised
$3.51M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cohesys is a medical device company that develops BoneTape, a bioresorbable fixation system for fracture repair intended to provide a less invasive alternative to metal plates and screws.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cohesys Comparables
Compare Cohesys with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RevBio, Inc. | 85% | |
| KLS Martin Group | 80% | |
| Hangzhou Yuannang Biotechnology Co., Ltd. | 78% |
Cohesys Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 13, 2025 | ||||
| Accelerator | Jun 5, 2025 | ||||
| Grant | Jul 8, 2024 | ||||
| Grant | Jan 29, 2024 | ||||
| Grant | May 30, 2022 | ||||
Angel | Oct 14, 2019 |
Key People
Founding team and executive leadership
Cohesys Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Royal Bank Of Canada | Grant |
| Ontario Bioscience Innovation Organization | Grant |
| MedTech Innovator | Grant, Accelerator |
| U.S. Army Medical Research and Development Command | Grant |
| University of Toronto Asset Management Corporation | Grant |
| University of Toronto Early Stage Technology | Pre Seed, Grant |
| Creative Destruction Lab | Pre Seed, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 13, 2025
Received $10K from Medical Technology Enterprise Consortium and Ontario Brain Institute.
- Jun 5, 2025
Received funding from MedTech Innovator.
Cohesys Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cohesys's valuation, stock price, and market status.
Is Cohesys a public or private company?
Cohesys is a private company.
What is the current stock price of Cohesys?
Cohesys is a private company with no public stock price. No recent secondary market data is available.
How much is Cohesys worth (valuation)?
Valuation information for Cohesys is not publicly available.
Can I buy Cohesys stock?
Cohesys shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cohesys's last funding round?
Cohesys's most recent funding round was Grant on October 13, 2025.
Who are the main investors in Cohesys?
Key investors in Cohesys include RBC, MedTech Innovator, U.S. Army Medical Research and Development Command, National Research Council Canada Industrial Research Assistance Program, Lundquist College of Business.
Will Cohesys IPO soon?
No public IPO plans have been announced for Cohesys.
How can I track Cohesys secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cohesys's secondary market activity and sign up for updates.